Akzo Nobel N.V.

ENXTAM:AKZA Stock Report

Market Cap: €9.8b

Akzo Nobel Management

Management criteria checks 2/4

Akzo Nobel's CEO is Greg Poux-Guillaume, appointed in Nov 2022, has a tenure of 3.58 years. total yearly compensation is €6.29M, comprised of 20.5% salary and 79.5% bonuses, including company stock and options. directly owns 0.043% of the company’s shares, worth €4.26M. The average tenure of the management team and the board of directors is 2.9 years and 2.2 years respectively.

Key information

Greg Poux-Guillaume

Chief executive officer

€6.3m

Total compensation

CEO salary percentage20.50%
CEO tenure3.6yrs
CEO ownership0.04%
Management average tenure2.9yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

Narrative Update Jun 02

AKZA: Margin Delivery And Downgrade Reset Will Shape Fairly Valued Repricing

Akzo Nobel's analyst price target has been cut by around €1 to €61, as analysts factor in more cautious assumptions on revenue growth and profitability following recent target reductions and downgrades from several major banks. Analyst Commentary Recent Street research on Akzo Nobel clusters around a series of target cuts and rating downgrades, with most analysts reworking their valuation frameworks to reflect more cautious assumptions on revenue growth and profitability.
Narrative Update May 02

AKZA: Margin Execution Is Expected To Support Repricing After Recent Downgrades

Akzo Nobel's updated analyst price target edges lower to about €62.60, as analysts factor in Street target cuts and downgrades, a slightly higher discount rate, and a more conservative future P/E assumption, despite using stronger revenue growth and profit margin inputs. Analyst Commentary Recent Street research on Akzo Nobel has focused on resetting expectations, with several firms lowering price targets and issuing downgrades.
Narrative Update Apr 17

AKZA: Margin Delivery Is Expected To Support Repricing After Recent Downgrades

Akzo Nobel's analyst price target has been trimmed by about €1.35. This reflects analysts' updated assumptions for slightly softer revenue growth and valuation multiples, partly balanced by a small uplift in expected profit margins.
New Narrative Apr 16

Merger Synergies And Cost Programs Will Create A More Powerful Coatings Leader

Catalysts About Akzo Nobel Akzo Nobel is a global paints and coatings company serving decorative, industrial, automotive, marine, aerospace and packaging customers. What are the underlying business or industry changes driving this perspective?
Narrative Update Apr 03

AKZA: Rebased Earnings And Margins Are Expected To Support Upside Repricing

Akzo Nobel's analyst fair value estimate has been trimmed by €2 to €65, as analysts factor in a series of recent downgrades and lower price targets, along with updated assumptions for growth, margins and future P/E levels. Analyst Commentary Recent Street research on Akzo Nobel presents a mix of cautious and constructive views, with several downgrades and price target cuts offset by at least one upward adjustment to fair value.
New Narrative Apr 02

Cost Synergies And Portfolio Pruning Will Shape A Steady Long Term Coatings Platform

Catalysts About Akzo Nobel Akzo Nobel is a global paints and coatings company supplying decorative paints and performance coatings to customers across construction, industrial and transportation end markets. What are the underlying business or industry changes driving this perspective?
Narrative Update Mar 20

AKZA: Rebased Earnings Assumptions Will Support Upside Repricing Potential

Akzo Nobel's updated analyst price target has shifted modestly to €67.00, as analysts factor in a slightly higher discount rate, more conservative revenue growth and profit margin assumptions, and recalibrated P/E expectations despite mixed recent research views on the stock. Analyst Commentary Recent research on Akzo Nobel reflects a mix of optimism around upside potential and caution around execution risk, which together help explain the updated €67.00 price target.
Analysis Article Feb 15

We Think You Should Be Aware Of Some Concerning Factors In Akzo Nobel's (AMS:AKZA) Earnings

Akzo Nobel N.V.'s ( AMS:AKZA ) healthy profit numbers didn't contain any surprises for investors. We believe that...
Narrative Update Feb 05

AKZA: Axalta Merger Will Expand Scale And Recast Earnings Potential

Narrative Update The analyst price target for Akzo Nobel is updated to €68.12 from €69.65, reflecting mixed research views. Some analysts cite more measured expectations around the Axalta merger, muted coatings growth and a modest synergy timeline, while others maintain higher targets closer to €75 supported by their own assessments.
Narrative Update Jan 18

AKZA: Axalta Merger Will Reshape Scale And Earnings Profile

Analysts have nudged their fair value estimate for Akzo Nobel to €69.65 from €68.94, reflecting updated assumptions around revenue growth, margins and the Axalta merger, which align with recent Street price target moves between €59 and €75. Analyst Commentary Recent Street research around Akzo Nobel and its merger with Axalta provides a mixed but useful set of signals to consider when thinking about valuation, execution risk and growth potential.
Analysis Article Jan 12

Akzo Nobel (AMS:AKZA) Could Be At Risk Of Shrinking As A Company

When researching a stock for investment, what can tell us that the company is in decline? When we see a declining...
Analysis Article Dec 05

Is Akzo Nobel (AMS:AKZA) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Oct 22

Why Investors Shouldn't Be Surprised By Akzo Nobel N.V.'s (AMS:AKZA) P/E

With a price-to-earnings (or "P/E") ratio of 25.2x Akzo Nobel N.V. ( AMS:AKZA ) may be sending bearish signals at the...
Analysis Article Oct 09

Are Investors Undervaluing Akzo Nobel N.V. (AMS:AKZA) By 43%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Akzo Nobel fair value estimate is €105 Akzo Nobel's €59.94...
Analysis Article Aug 31

Is Akzo Nobel (AMS:AKZA) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Aug 18

Is Now An Opportune Moment To Examine Akzo Nobel N.V. (AMS:AKZA)?

ENXTAM:AKZA 1 Year Share Price vs Fair Value Explore Akzo Nobel's Fair Values from the Community and select yours Let's...
Analysis Article Jul 17

Akzo Nobel N.V.'s (AMS:AKZA) Price In Tune With Earnings

When close to half the companies in the Netherlands have price-to-earnings ratios (or "P/E's") below 19x, you may...
Analysis Article Jun 21

Akzo Nobel's (AMS:AKZA) Returns Have Hit A Wall

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
User avatar
New Narrative Nov 19

Steady Streamlining And Strategic Expansion Ignite A Brighter Future

Efficiency programs and workforce reductions are set to bolster net margins through significant cost savings.

CEO Compensation Analysis

How has Greg Poux-Guillaume's remuneration changed compared to Akzo Nobel's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2026n/an/a

€622m

Dec 31 2025€6m€1m

€636m

Sep 30 2025n/an/a

€59m

Jun 30 2025n/an/a

€415m

Mar 31 2025n/an/a

€467m

Dec 31 2024€5m€1m

€542m

Sep 30 2024n/an/a

€565m

Jun 30 2024n/an/a

€592m

Mar 31 2024n/an/a

€534m

Dec 31 2023€5m€1m

€447m

Sep 30 2023n/an/a

€411m

Jun 30 2023n/an/a

€309m

Mar 31 2023n/an/a

€303m

Dec 31 2022€2m€204k

€362m

Compensation vs Market: Greg's total compensation ($USD7.25M) is above average for companies of similar size in the Dutch market ($USD4.12M).

Compensation vs Earnings: Greg's compensation has been consistent with company performance over the past year.


CEO

Greg Poux-Guillaume (56 yo)

3.6yrs
Tenure
€6,293,913
Compensation

Mr. Gregoire Poux-Guillaume, also known as Greg, is CEO & Chairman of the Management Board of Akzo Nobel N.V. from November 01, 2022. Mr. Poux-Guillaume was Member of Management Board of Akzo Nobel N.V. fr...


Leadership Team

NamePositionTenureCompensationOwnership
Gregoire Poux-Guillaume
CEO & Chairman of the Management Board3.6yrs€6.29m0.043%
€ 4.3m
Maarten de Vries
Member of Management Board8.4yrs€3.34m0.030%
€ 3.0m
Fredrik Westin
Chief Financial Officerless than a yearno datano data
Jan Enhus
Head of Investor Relationsno datano datano data
Charlotte Meer
General Counsel2.4yrsno datano data
Armand Sohet
Chief Human Resources Officer2.9yrsno datano data
Charles Shaver
CEO of Specialty Chemicals7.7yrsno datano data
Wiebe Wiechers
Chief Development Officer1.6yrsno datano data
2.9yrs
Average Tenure
56yo
Average Age

Experienced Management: AKZA's management team is considered experienced (2.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ben Noteboom
Independent Supervisory Board Chairman3.2yrs€184.00k0.0013%
€ 131.5k
Hans Van Bylen
Independent Member of Supervisory Board4.2yrs€116.09kno data
Hans Müller
Member of the Supervisory Board1.4yrs€78.58kno data
Wouter Kolk
Independent Member of Supervisory Board2.2yrs€106.09kno data
Jaska de Bakker
Independent Member of Supervisory Board2.2yrs€123.00kno data
Ute Wolf
Independent Member of Supervisory Board2.2yrs€133.45kno data
Ester Baiget
Independent Member of Supervisory Board4.2yrs€116.41kno data
Robert Schuchna
Member of Supervisory Boardless than a yearno datano data
2.2yrs
Average Tenure
60yo
Average Age

Experienced Board: AKZA's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/08 14:59
End of Day Share Price 2026/06/05 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Akzo Nobel N.V. is covered by 40 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Katie RichardsBarclays
Jennifer BarkerBarclays
Robert BateBarclays